Mitochondrial transplantation as a novel therapeutic strategy for cardiovascular diseases

被引:0
|
作者
Mingchu Sun
Wenhua Jiang
Nan Mu
Zihui Zhang
Lu Yu
Heng Ma
机构
[1] Northwestern Polytechnical University,Institute of Medical Research
[2] Fourth Military Medical University,Department of Physiology and Pathophysiology, School of Basic Medical Sciences
[3] Fourth Military Medical University,Department of Pathology, Xijing Hospital
关键词
Cardiovascular diseases; Mitochondrial dysfunction; Mitochondrial transplantation; Ischemia reperfusion injury; Therapy;
D O I
暂无
中图分类号
学科分类号
摘要
Cardiovascular disease (CVD) is the leading cause of noncommunicable disease-related death worldwide, and effective therapeutic strategies against CVD are urgently needed. Mitochondria dysfunction involves in the onset and development of CVD. Nowadays, mitochondrial transplantation, an alternative treatment aimed at increasing mitochondrial number and improving mitochondrial function, has been emerged with great therapeutic potential. Substantial evidence indicates that mitochondrial transplantation improves cardiac function and outcomes in patients with CVD. Therefore, mitochondrial transplantation has profound implications in the prevention and treatment of CVD. Here, we review the mitochondrial abnormalities that occur in CVD and summarize the therapeutic strategies of mitochondrial transplantation for CVD.
引用
收藏
相关论文
共 50 条
  • [1] Mitochondrial transplantation as a novel therapeutic strategy for cardiovascular diseases
    Sun, Mingchu
    Jiang, Wenhua
    Mu, Nan
    Zhang, Zihui
    Yu, Lu
    Ma, Heng
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)
  • [2] Mitochondrial Transplantation as a Novel Therapeutic Strategy for Mitochondrial Diseases
    Park, Anna
    Oh, Mihee
    Lee, Su Jeong
    Oh, Kyoung-Jin
    Lee, Eun-Woo
    Lee, Sang Chul
    Bae, Kwang-Hee
    Han, Baek Soo
    Kim, Won Kon
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (09)
  • [3] A novel therapeutic strategy against mitochondrial diseases: redox cyclers.
    Bonesso, Daniele
    Peruzzo, Roberta
    Rossa, Andrea
    Mattarei, Andrea
    Zeviani, Massimo
    Viscomi, Carlo
    Szabo, Ildiko
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 2022, 1863 : 100 - 100
  • [4] Targeting the microRNA-34a as a Novel Therapeutic Strategy for Cardiovascular Diseases
    Hua, Cun-Cun
    Liu, Xin-Ming
    Liang, Li-Rong
    Wang, Le-Feng
    Zhong, Jiu-Chang
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 8
  • [5] Mitochondrial Dysfunction and Therapeutic Perspectives in Cardiovascular Diseases
    Liu, Yu
    Huang, Yuejia
    Xu, Chong
    An, Peng
    Luo, Yongting
    Jiao, Lei
    Luo, Junjie
    Li, Yongzhi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (24)
  • [6] Mitochondrial transplant to replenish damaged mitochondria: A novel therapeutic strategy for neurodegenerative diseases?
    Mukherjee, Abhisek
    Calixto, Andrea D. Becerra
    Chavez, Melissa
    Delgado, Jean Paul
    Soto, Claudio
    MOLECULAR BIOLOGY OF NEURODEGENERATIVE DISEASES: VISIONS FOR THE FUTURE, PT B, 2021, 177 : 49 - 63
  • [7] Therapeutic potential of mitochondrial transplantation in ocular diseases
    Rotfogel, Ziv
    Zaks, Ortal
    Bader, Maya Sharvit
    Marcovich, Arie
    Ben Yaakov, Keren
    Simon, Michal
    Leiba, Hana
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [8] Endothelin receptor signalosome as a target for a novel therapeutic strategy against cardiovascular diseases
    Horinouchi, Takahiro
    Terada, Koji
    Higashi, Tsunehito
    Hoshi, Akimasa
    Miwa, Soichi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2014, 124 : 22P - 22P
  • [9] MicroRNA: A new therapeutic strategy for cardiovascular diseases
    Samanta, Saheli
    Balasubramanian, Sathyamoorthy
    Rajasingh, Sheeja
    Patel, Urmi
    Dhanasekaran, Anuradha
    Dawn, Buddhadeb
    Rajasingh, Johnson
    TRENDS IN CARDIOVASCULAR MEDICINE, 2016, 26 (05) : 407 - 419
  • [10] Mechanical stress induced mitochondrial dysfunction in cardiovascular diseases: Novel mechanisms and therapeutic targets
    Ren, He
    Hu, Weiyi
    Jiang, Tao
    Yao, Qingping
    Qi, Yingxin
    Huang, Kai
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 174